Intriguingly, we found that the nuclear distribution of KIAA1429 was significantly associated with tumor regression grade (TRG) following neoadjuvant therapy in CRC patients (Fig. 1D, E, F; Table S4). The gene discussed is VIRMA; the disease is colorectal carcinoma.